CDK4 and neoplasm: In tumors where Met and Cdk4 were not amplified (n = 3) or the amplification status was unknown due to lack of WES (n = 10), the expression of these genes was significantly upregulated, suggesting that activation of these oncogenes is selected for during tumor development either by amplification or alternative mechanisms (Fig. 5B and C).